Anthony Kerbage
@KerbageAnthony
Followers
2K
Following
3K
Media
92
Statuses
974
IM Resident @ClevelandClinic MD’20 @USJLiban🇱🇧
Cleveland, OH
Joined November 2019
Congratulations to Scott Gabbard for his Governor’s award for work on a sleep positioning device to reduce acid exposure and improve lung function in lung transplant recipients. #ACG2025 @MichelleKimMD @CCF_GIFellows @Chatterjee_MD @Ari_G_MD @HishamWehbeMD @IBD_Afzali
1
10
46
We were thrilled with the overflowing love & passion you brought to @MENAGastro reception. Thank you to our fearless leader @maysaazoghbi, our fairy godmother @DCharabaty & organizing team @JosephHabibi_MD @mayyismail Special🙏@TakedaPharma for supporting our mission
1
20
41
Great Cleveland Clinic GI reception at #ACG2025 tonight- wonderful turnout of friends, both old and new. @MRegueiroMD @MichelleKimMD @CCF_GIFellows @Chatterjee_MD @JP_Park_MD @Ari_G_MD @FnuVikash @KatieFalloonMD @XiaoliangWangMD @mattie_md @NealMehtaMD @AdamKichlerDO @GavinSong1
1
24
64
@KerbageAnthony presenting data showing no difference in colonoscopic depth of insertion between male & female endoscopists although female endoscopists did more procedures on females- ?gender based differences in technique to account for variation in patient factors. #ACG2025
0
7
19
Great chatting with @GastroEndoNews about CRC surveillance in older adults with Lynch syndrome, and why continued screening still matters after 65. Looking forward to sharing further data on those over 75 at @AmCollegeGastro in Phoenix! Read more ⬇️
👵🧬 New study: Lynch syndrome patients should continue colonoscopy surveillance past age 65. Advanced neoplasia risk remains high—>50% at 10 years, with low complication rates https://t.co/rkKo3vpQe8
#LynchSyndrome #ColonCancer #Gastroenterology
0
2
13
Couldn’t be prouder!!! ❤️❤️❤️ @CCF_IMCHIEFS
Honored to be included among the 2025 Conquer Cancer Merit Award recipients!🎈 Grateful for @ConquerCancerFd @ASCO for this recognition, and the team who made it possible @DavidLiskaMD Excited to learn and present at the upcoming #ASCOQLTY25 in Chicago! https://t.co/ISFRHRDEBn
0
0
16
Our group was the first to define POSED (Post-Obesity Surgery Esophageal Dysfunction), a newly recognized motility disorder that can develop in a subset of patients after metabolic bariatric surgery. In our latest @NGMJournal Neurogastroenterology & Motility study, we uncover a
3
25
95
Happy to share our study on the quality of 📷photodocumentation of large colorectal polyps! Despite guideline recommendations, high-quality photodocumentation is often lacking, with fewer than 60% of cases meeting quality criteria. 📖 Full article: https://t.co/Sm3KtnIz58
5
6
43
Incredibly proud of @SouaidTarek for the release of his first book! How Doctors Grow isn’t just for doctors, it’s for anyone who believes in learning through human connection. Thoughtful, honest, and deeply moving. Highly recommend grabbing a copy ⬇️:
amazon.com
There is a moment in every doctor’s life when they realize that medicine is not just about diseases, nor even about treatments. It is about people. It is about stories. It is about change. I entered...
🌿Happy to announce that my first #book, How Doctors Grow, is now published on Amazon ⭐️ ⭐️ ⭐️ ⭐️ ⭐️ 🔗 Grab your copy now! → https://t.co/uIGWkAMaHJ After years of bedside learning, I’ve distilled my journey into 9 lessons, the 9 pillars of doctors’ growth. Let’s grow
1
4
22
Had a great time speaking with @HCPLiveNews about our study on language-based disparities in CRC screening. We found that non-English primary language was linked to increased risk of early repeat colonoscopy, highlighting the need for more equitable, language-accessible care.
Hear from @KerbageAnthony @ClevelandClinic about the impact of language barriers on bowel preparation for #colonoscopy and the subsequent need for repeat colonoscopies. Full interview: https://t.co/4uofZYAA5y
9
5
42
🚨 Just out in @CirculationEP: Our U.S. national study shows rising stroke mortality in AFib/Flutter. Women with AFib are more likely to die from stroke than men. Eye-opening findings. Grateful to @omwazni, our team, @CleClinicHVTI & @CCF_IMCHIEFS.
Stroke mortality in AF/AFL has risen over two decades, with persistent sex disparities. Identifying high-risk groups is key to refining prevention strategies @IMotairek @omwazni @CleClinicHVTI #AHAJournals #Epeeps
https://t.co/0ezpokt6t8
10
7
41
🚀 Innovation week is off to a strong start at @CCF_IMCHIEFS @ClevelandClinic Thank you @BrandonCornuke for breaking down your Value Proposition Matrix and helping us apply it to healthcare! Today, we were challenged as internal medicine residents to think like innovators: 1-
4
4
29
Had a blast at #DDW2025☀️! Grateful for the @AmerGastroAssn for recognizing our work with an AGA abstract award, but even more for the chance to catch up with old friends, make new ones, and learn so much. Incredibly thankful for my mentors @burkegastrodoc @AnthonyLemboMD !
13
4
66
Grateful for an incredible week at #DDW2025 in San Diego. It was a great opportunity to present our work, learn from inspiring colleagues, and reconnect with friends and mentors. Looking forward to carrying this momentum forward! @CCF_IMCHIEFS @CCF_GIFellows @ClevelandClinic
7
4
76
🔬Our annual #DDW team photo! Grateful to be part of this incredible team led by the one and only Dr. Abu Dayyeh @babudayyeh
0
1
52
1
7
48
Key Takeaways: 🧪 A personalized IgG-guided elimination diet led to greater symptom relief in IBS 🙌 Especially promising in IBS-C & IBS-M 🔄 Study was sham-controlled & double-blinded 🚀 This could be a major step toward precision nutrition for IBS #GITwitter #IBS
1
1
7
💡Why This Matters Low-FODMAP works for many, but it’s restrictive, hard to follow, and non-personalized ⭐️This IgG-guided diet: - Uses a test specifically designed for IBS - Offers a simpler, precision-based alternative - Could fill a gap in care, especially for IBS-C & IBS-M
1
1
7
Pain improved in: ✅ 59.6% of IgG-diet patients ❌ 42.1% of sham-diet patients Statistically significant (P = 0.02) Biggest benefits were seen in IBS-C & IBS-M subtypes
1
1
5
🧑🧑🧒🧒 238 adults with IBS (per Rome IV criteria) 📋 Randomized to: IgG-guided diet vs. Sham diet (eliminated foods not based on IgG) ⏱️ 8-week intervention 🔎Double-blind, multicenter, sham-controlled 🎯 Primary outcome = ≥30% drop in abdominal pain (FDA standard)
1
1
5